Associate Professor Rebecca McKetin is a Curtin Research Fellow at the National Drug Research Institute. Much of Rebecca’s research has focussed on methamphetamine (‘ice’ or ‘crystal meth’), for which she has received a NSW/ACT Young Tall Poppy Science Award.
Her major achievements include developing methods to estimate the number of people dependent on methamphetamine use in Australia, establishing a world-first longitudinal treatment outcomes study for methamphetamine use (the Methamphetamine Treatment Evaluation Study), quantifying the risk of mental health problems associated with the use of the drug, and developing an online intervention for people who use methamphetamine (Breaking the Ice).
She is currently an investigator on NHMRC funded research to develop novel responses to methamphetamine use in Aboriginal communities, to trial two new medications for methamphetamine dependence (N-acetylcysteine and lisdexamfetamine), and a longitudinal cohort study examining the relationship between mental health and mid-life outcomes.
Rebecca's research has attracted high-profile media coverage both in Australia and internationally, and has been used in parliamentary enquiries and the National Ice Taskforce. She has also worked as an epidemiologist for the United Nations, consulting to them on the development of drug monitoring systems in Asia and Africa. She is currently Drug and Alcohol Review’s Regional Editor for Asia, an Assistant Editor for Addiction, and a member of the Australian Institute of Policy and Science.